Clinical trial
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
NCT00448734 · Poniard Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00448734 |
|---|---|
| Title | A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer |
| Official title | A Phase 1/2 Study of Picoplatin and Docetaxel (With Prednisone) in Subjects With Chemotherapy-Naive Metastatic Hormone-Refractory Prostate Cancer |
| Lead sponsor | Poniard Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hormone Refractory Prostate Cancer |
| Intervention type | Drug |
| Interventions | Picoplatin, docetaxel |
| Enrollment | 95 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Mar 19, 2007 |
| Last update posted | Jan 21, 2009 |
| Countries | Russia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: